TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2029

G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2029

  • Category:Life Sciences
  • Published on : 16 June 2023
  • Pages :78
  • Formats:
  • Report Code:SMR-7724745
OfferClick for best price

Best Price: $2600

GCSF Biosimilars Market Size, Share 2023


Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.

This report aims to provide a comprehensive presentation of the global market for G-CSF Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G-CSF Biosimilars. This report contains market size and forecasts of G-CSF Biosimilars in global, including the following market information:

Global G-CSF Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global G-CSF Biosimilars Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five G-CSF Biosimilars companies in 2022 (%)

The global G-CSF Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor

Company profiles are primarily based on public domain information including company

Merck & Co.

Sanofi

Johnson & Johnson

Gilead Science

GlaxoSmithKline

AbbVie

Amgen

AstraZeneca

Bayer

Pfizer

Novartis

Roche

We surveyed the G-CSF Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global G-CSF Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global G-CSF Biosimilars Market Segment Percentages, by Type, 2022 (%)

Human Growth Hormone

Erythropoietin

Monoclonal Antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Global G-CSF Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global G-CSF Biosimilars Market Segment Percentages, by Application, 2022 (%)

Blood Disorders

Oncology Diseases

Chronic And Autoimmune Diseases

Growth Hormone Deficiencies

Global G-CSF Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global G-CSF Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies G-CSF Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies G-CSF Biosimilars revenues share in global market, 2022 (%)

Key companies G-CSF Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)

Key companies G-CSF Biosimilars sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer

Novartis

Roche

Merck & Co.

Sanofi

Johnson & Johnson

Gilead Science

GlaxoSmithKline

AbbVie

Amgen

AstraZeneca

Bayer

Outline of Major Chapters:

Chapter 1: Introduces the definition of G-CSF Biosimilars, market overview.

Chapter 2: Global G-CSF Biosimilars market size in revenue and volume.

Chapter 3: Detailed analysis of G-CSF Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of G-CSF Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global G-CSF Biosimilars capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Report Attributes Report Details
Report Title G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2029
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 78 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 G-CSF Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global G-CSF Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global G-CSF Biosimilars Overall Market Size
2.1 Global G-CSF Biosimilars Market Size: 2022 VS 2029
2.2 Global G-CSF Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global G-CSF Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top G-CSF Biosimilars Players in Global Market
3.2 Top Global G-CSF Biosimilars Companies Ranked by Revenue
3.3 Global G-CSF Biosimilars Revenue by Companies
3.4 Global G-CSF Biosimilars Sales by Companies
3.5 Global G-CSF Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 G-CSF Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers G-CSF Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 G-CSF Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 G-CSF Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global G-CSF Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Human Growth Hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal Antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.2 By Type - Global G-CSF Biosimilars Revenue & Forecasts
4.2.1 By Type - Global G-CSF Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global G-CSF Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global G-CSF Biosimilars Sales & Forecasts
4.3.1 By Type - Global G-CSF Biosimilars Sales, 2018-2023
4.3.2 By Type - Global G-CSF Biosimilars Sales, 2024-2029
4.3.3 By Type - Global G-CSF Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global G-CSF Biosimilars Market Size, 2022 & 2029
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic And Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.2 By Application - Global G-CSF Biosimilars Revenue & Forecasts
5.2.1 By Application - Global G-CSF Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global G-CSF Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global G-CSF Biosimilars Sales & Forecasts
5.3.1 By Application - Global G-CSF Biosimilars Sales, 2018-2023
5.3.2 By Application - Global G-CSF Biosimilars Sales, 2024-2029
5.3.3 By Application - Global G-CSF Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global G-CSF Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global G-CSF Biosimilars Revenue & Forecasts
6.2.1 By Region - Global G-CSF Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global G-CSF Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global G-CSF Biosimilars Sales & Forecasts
6.3.1 By Region - Global G-CSF Biosimilars Sales, 2018-2023
6.3.2 By Region - Global G-CSF Biosimilars Sales, 2024-2029
6.3.3 By Region - Global G-CSF Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America G-CSF Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America G-CSF Biosimilars Sales, 2018-2029
6.4.3 US G-CSF Biosimilars Market Size, 2018-2029
6.4.4 Canada G-CSF Biosimilars Market Size, 2018-2029
6.4.5 Mexico G-CSF Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe G-CSF Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe G-CSF Biosimilars Sales, 2018-2029
6.5.3 Germany G-CSF Biosimilars Market Size, 2018-2029
6.5.4 France G-CSF Biosimilars Market Size, 2018-2029
6.5.5 U.K. G-CSF Biosimilars Market Size, 2018-2029
6.5.6 Italy G-CSF Biosimilars Market Size, 2018-2029
6.5.7 Russia G-CSF Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries G-CSF Biosimilars Market Size, 2018-2029
6.5.9 Benelux G-CSF Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia G-CSF Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia G-CSF Biosimilars Sales, 2018-2029
6.6.3 China G-CSF Biosimilars Market Size, 2018-2029
6.6.4 Japan G-CSF Biosimilars Market Size, 2018-2029
6.6.5 South Korea G-CSF Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia G-CSF Biosimilars Market Size, 2018-2029
6.6.7 India G-CSF Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America G-CSF Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America G-CSF Biosimilars Sales, 2018-2029
6.7.3 Brazil G-CSF Biosimilars Market Size, 2018-2029
6.7.4 Argentina G-CSF Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa G-CSF Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa G-CSF Biosimilars Sales, 2018-2029
6.8.3 Turkey G-CSF Biosimilars Market Size, 2018-2029
6.8.4 Israel G-CSF Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia G-CSF Biosimilars Market Size, 2018-2029
6.8.6 UAE G-CSF Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer G-CSF Biosimilars Major Product Offerings
7.1.4 Pfizer G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis G-CSF Biosimilars Major Product Offerings
7.2.4 Novartis G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche G-CSF Biosimilars Major Product Offerings
7.3.4 Roche G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. G-CSF Biosimilars Major Product Offerings
7.4.4 Merck & Co. G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi G-CSF Biosimilars Major Product Offerings
7.5.4 Sanofi G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson G-CSF Biosimilars Major Product Offerings
7.6.4 Johnson & Johnson G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Gilead Science
7.7.1 Gilead Science Company Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science G-CSF Biosimilars Major Product Offerings
7.7.4 Gilead Science G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Gilead Science Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline G-CSF Biosimilars Major Product Offerings
7.8.4 GlaxoSmithKline G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie G-CSF Biosimilars Major Product Offerings
7.9.4 AbbVie G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen G-CSF Biosimilars Major Product Offerings
7.10.4 Amgen G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca G-CSF Biosimilars Business Overview
7.11.3 AstraZeneca G-CSF Biosimilars Major Product Offerings
7.11.4 AstraZeneca G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bayer
7.12.1 Bayer Company Summary
7.12.2 Bayer G-CSF Biosimilars Business Overview
7.12.3 Bayer G-CSF Biosimilars Major Product Offerings
7.12.4 Bayer G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Bayer Key News & Latest Developments
8 Global G-CSF Biosimilars Production Capacity, Analysis
8.1 Global G-CSF Biosimilars Production Capacity, 2018-2029
8.2 G-CSF Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global G-CSF Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 G-CSF Biosimilars Supply Chain Analysis
10.1 G-CSF Biosimilars Industry Value Chain
10.2 G-CSF Biosimilars Upstream Market
10.3 G-CSF Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 G-CSF Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of G-CSF Biosimilars in Global Market
Table 2. Top G-CSF Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global G-CSF Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global G-CSF Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global G-CSF Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global G-CSF Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers G-CSF Biosimilars Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers G-CSF Biosimilars Product Type
Table 9. List of Global Tier 1 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global G-CSF Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global G-CSF Biosimilars Sales (K Units), 2024-2029
Table 16. By Application ? Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global G-CSF Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global G-CSF Biosimilars Sales (K Units), 2024-2029
Table 21. By Region ? Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global G-CSF Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global G-CSF Biosimilars Sales (K Units), 2024-2029
Table 26. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America G-CSF Biosimilars Sales, (K Units), 2024-2029
Table 30. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2024-2029
Table 34. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2024-2029
Table 38. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America G-CSF Biosimilars Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer G-CSF Biosimilars Product Offerings
Table 48. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis G-CSF Biosimilars Product Offerings
Table 52. Novartis G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche G-CSF Biosimilars Product Offerings
Table 56. Roche G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. G-CSF Biosimilars Product Offerings
Table 60. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi G-CSF Biosimilars Product Offerings
Table 64. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson G-CSF Biosimilars Product Offerings
Table 68. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Gilead Science Company Summary
Table 71. Gilead Science G-CSF Biosimilars Product Offerings
Table 72. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Gilead Science Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline G-CSF Biosimilars Product Offerings
Table 76. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. AbbVie Company Summary
Table 79. AbbVie G-CSF Biosimilars Product Offerings
Table 80. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. AbbVie Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen G-CSF Biosimilars Product Offerings
Table 84. Amgen G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca G-CSF Biosimilars Product Offerings
Table 88. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Bayer Company Summary
Table 91. Bayer G-CSF Biosimilars Product Offerings
Table 92. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bayer Key News & Latest Developments
Table 94. G-CSF Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global G-CSF Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global G-CSF Biosimilars Production by Region, 2018-2023 (K Units)
Table 97. Global G-CSF Biosimilars Production by Region, 2024-2029 (K Units)
Table 98. G-CSF Biosimilars Market Opportunities & Trends in Global Market
Table 99. G-CSF Biosimilars Market Drivers in Global Market
Table 100. G-CSF Biosimilars Market Restraints in Global Market
Table 101. G-CSF Biosimilars Raw Materials
Table 102. G-CSF Biosimilars Raw Materials Suppliers in Global Market
Table 103. Typical G-CSF Biosimilars Downstream
Table 104. G-CSF Biosimilars Downstream Clients in Global Market
Table 105. G-CSF Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. G-CSF Biosimilars Segment by Type in 2022
Figure 2. G-CSF Biosimilars Segment by Application in 2022
Figure 3. Global G-CSF Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global G-CSF Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global G-CSF Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. G-CSF Biosimilars Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by G-CSF Biosimilars Revenue in 2022
Figure 9. By Type - Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 11. By Type - Global G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 12. By Type - Global G-CSF Biosimilars Price (USD/Unit), 2018-2029
Figure 13. By Application - Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Application - Global G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 16. By Application - Global G-CSF Biosimilars Price (USD/Unit), 2018-2029
Figure 17. By Region - Global G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global G-CSF Biosimilars Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 20. By Region - Global G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 21. By Country - North America G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 22. By Country - North America G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 23. US G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Canada G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 27. By Country - Europe G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 28. Germany G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. France G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Italy G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. Russia G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 36. By Region - Asia G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 37. China G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Japan G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. India G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 43. By Country - South America G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 44. Brazil G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa G-CSF Biosimilars Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa G-CSF Biosimilars Sales Market Share, 2018-2029
Figure 48. Turkey G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 49. Israel G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 51. UAE G-CSF Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 52. Global G-CSF Biosimilars Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production G-CSF Biosimilars by Region, 2022 VS 2029
Figure 54. G-CSF Biosimilars Industry Value Chain
Figure 55. Marketing Channels

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount